{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:10Z","timestamp":1793810710198,"version":"4.6.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/gme.0b013e3181c1ac01","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:37Z","timestamp":1268890477000},"page":"480-486","source":"Crossref","is-referenced-by-count":204,"title":["Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women"],"prefix":"10.1097","volume":"17","author":[{"given":"Gloria A.","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne O.","family":"Komi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210227","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis.","volume":"61","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"key":"R2-9-20210227","first-page":"17","article-title":"Update on vaginal atrophy.","volume":"14","author":"Nachtigall","year":"2005","journal-title":"Menopause Manag"},{"key":"R3-9-20210227","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women.","volume":"6","author":"Santoro","year":"2009","journal-title":"J Sex Med"},{"key":"R4-9-20210227","first-page":"1107","article-title":"Postmenopausal women's attitudes: vulvovaginal atrophy and its symptoms abstract LB-10.","volume":"14","author":"Simon","year":"2007","journal-title":"Menopause"},{"key":"R5-9-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in healthy postmenopausal women.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R6-9-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/gme.0b013e31817b076a","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.","volume":"15","year":"2008","journal-title":"Menopause"},{"key":"R7-9-20210227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/gme.0b013e318051718c","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R8-9-20210227","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-9-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"R10-9-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R11-9-20210227","first-page":"1392","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053-1060.","volume":"112","author":"Simon","year":"2008","journal-title":"Erratum in: Obstet Gynecol"},{"key":"R12-9-20210227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/gme.0b013e3181924701","article-title":"Vulvovaginal atrophy: new and upcoming approaches.","volume":"16","author":"Simon","year":"2009","journal-title":"Menopause"},{"key":"R13-9-20210227","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/endo.141.2.7342","article-title":"Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.","volume":"141","author":"Qu","year":"2000","journal-title":"Endocrinology"},{"key":"R14-9-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(01)00066-8","article-title":"In vitro and in vivo biologic effects of ospemifene (FC-1271a) in breast cancer.","volume":"77","author":"Taras","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R15-9-20210227","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2005.06.027","article-title":"Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice.","volume":"97","author":"Wurz","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R16-9-20210227","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/bcr1317","article-title":"Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.","volume":"7","author":"Namba","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R17-9-20210227","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.GME.0000063566.84134.98","article-title":"Effects of ospemifene, a novel SERM, on vascular markers and function in healthy postmenopausal women.","volume":"10","author":"Ylikorkala","year":"2003","journal-title":"Menopause"},{"key":"R18-9-20210227","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.GME.0000063609.62485.27","article-title":"Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and on quality of life in postmenopausal women: a double-blind randomized trial.","volume":"10","author":"Rutanen","year":"2003","journal-title":"Menopause"},{"key":"R19-9-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590410001672197","article-title":"Effects of ospemifene, a novel SERM, on biological markers of bone turnover in healthy postmenopausal women.","volume":"18","author":"Komi","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"R20-9-20210227","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00042192-200512020-00015","article-title":"Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract and tolerability in postmenopausal women.","volume":"12","author":"Komi","year":"2005","journal-title":"Menopause"},{"key":"R21-9-20210227","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00774-006-0689-9","article-title":"Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women.","volume":"24","author":"Komi","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"R23-9-20210227","first-page":"97","article-title":"Ospemifene, a new SERM, improves the symptoms of vaginal dryness and dyspareunia in postmenopausal women: results from a pivotal phase 3 study abstract OR6-03.","volume":"11","author":"Simon","year":"2008","journal-title":"Climacteric"},{"key":"R24-9-20210227","first-page":"1222","article-title":"Ospemifene improves the clinical signs of vaginal atrophy: results from a pivotal phase 3 study abstract P48.","volume":"15","author":"Portman","year":"2008","journal-title":"Menopause"},{"key":"R26-9-20210227","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1071-5576(99)00054-4","article-title":"Selective estrogen receptor modulators (SERMs) in clinical practice.","volume":"7","author":"Plouffe","year":"2000","journal-title":"J Soc Gynecol Investig"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e3181c1ac01","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:23Z","timestamp":1786040123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201017030-00009"}},"subtitle":["results from a pivotal phase 3 study"],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181c1ac01","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}